Loading clinical trials...
Loading clinical trials...
This trial is conducted in Africa, Asia, Europe, North and South America and Oceania. The aim of the trial is to evaluate the effect of somatropin (human growth hormone) on survival (primary end-poin...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novo Nordisk A/S
NCT05398783 · Metabolic Disorders, Cancer, and more
NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more
NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus
NCT05196035 · Chronic Kidney Disease, Proteinuria
NCT06721143 · Chronic Kidney Disease Stage 3
Novo Nordisk Investigational Site
Alexander City, Alabama
Novo Nordisk Investigational Site
Birmingham, Alabama
Novo Nordisk Investigational Site
Madison, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions